TP53 and cancer: However interestingly, the inhibition of p53 in the cancer and Ca&AD groups of patients in this study induced and increase in survival, which is opposite to the effect of p53 inhibition in lymphocytes from AD patients and HC subjects in our previous report (Figure 6) (Salech et al., 2017).